ArticlePloS one2017
Economics of One Health: Costs and benefits of integrated West Nile virus surveillance in Emilia-Romagna.
Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The impact of climate change on neglected tropical diseases: a systematic review.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2021Pooled it
- Early-warning surveillance of West Nile and Usutu viruses in wetland and larval habitat waters and in mosquito excreta using digital PCR.PLoS neglected tropical diseases · 2026Article
- Integrated approaches to health: A paradigmatic, methodological and operational comparison of EcoHealth, One Health and Planetary Health.CABI one health · 2025Article
- Ecological niche and risk modeling of West Nile virus using environmental and biological thresholds.Archives of microbiology · 2025Article
- Transfusion-transmitted infections: risks and mitigation strategies for Oropouche virus and other emerging arboviruses in Latin America and the Caribbean.Lancet regional health. Americas · 2025Review
- One Health Economics approach to prevention and control of zoonotic and animal diseases - considerations for South Africa.One health outlook · 2025Article
- West Nile Virus (WNV): One-Health and Eco-Health Global Risks.Veterinary sciences · 2025Review
- The monitoring of emergent zoonotic pathogens in wild and captive birds in Sarajevo Canton, Bosnia and Herzegovina.Frontiers in veterinary science · 2025Article
- Current evidence of the economic value of One Health initiatives: A systematic literature review.One health (Amsterdam, Netherlands) · 2024Review
- Lessons Learned from West Nile Virus Infection:Vaccinations in Equines and Their Implications for One Health Approaches.Viruses · 2024Review
- Assessing the Adoption of One Health Approaches in National Plans to Combat Health Threats: The Pilot of a One Health Conceptual Framework in Armenia.Tropical medicine and infectious disease · 2024Article
- West Nile virus surveillance using sentinel birds: results of eleven years of testing in corvids in a region of northern Italy.Frontiers in veterinary science · 2024Article
- Developing One Health surveillance systems.One health (Amsterdam, Netherlands) · 2023Review
- Knowledge management tools and mechanisms for evidence-informed decision-making in the WHO European Region: a scoping review.Health research policy and systems · 2023Article
- A modified BG-Sentinel trap equipped with FTA card as a novel tool for mosquito-borne disease surveillance: a field test for flavivirus detection.Scientific reports · 2023Article
- Article
- One Health-Key to Adequate Intervention Measures against Zoonotic Risks.Pathogens (Basel, Switzerland) · 2023Article
- West Nile Virus Infection: A Cross-Sectional Study on Italian Medical Professionals during Summer Season 2022.Tropical medicine and infectious disease · 2022Article
- First evidence of pyrethroid resistance in Italian populations of West Nile virus vector Culex pipiens.Medical and veterinary entomology · 2022Article
- One Health surveillance of West Nile and Usutu viruses: a repeated cross-sectional study exploring seroprevalence and endemicity in Southern France, 2016 to 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since 2013 in Emilia-Romagna, Italy, surveillance information generated in the public health and in the animal health sectors has been shared and used to guide public health interventions to mitigate the risk of West Nile virus (WNV) transmission via blood transfusion. The objective of the current study was to identify and estimate the costs and benefits associated with this One Health surveillance approach, and to compare it to an approach that does not integrate animal health information in blood donations safety policy (uni-sectoral scenario). Costs of human, animal, and entomological surveillance, sharing of information, and triggered interventions were estimated. Benefits were quantified as the averted costs of potential human cases of WNV neuroinvasive disease associated to infected blood transfusion. In the 2009-2015 period, the One Health approach was estimated to represent a cost saving of €160,921 compared to the uni-sectoral scenario. Blood donation screening was the main cost for both scenarios. The One Health approach further allowed savings of €1.21 million in terms of avoided tests on blood units. Benefits of the One Health approach due to short-term costs of hospitalization and compensation for transfusion-associated disease potentially avoided, were estimated to range from €0 to €2.98 million according to the probability of developing WNV neuroinvasive disease after receiving an infected blood transfusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.